As part of its efforts to expand into the biotech market, Johnson & Johnson is making a long-anticipated bid for Dutch vaccine maker Crucell — in spite of Crucell’s recent manufacturing troubles.
Continue reading Johnson & Johnson Launches Offer for Crucell
Johnson & Johnson Launches Offer for Crucell originally appeared on DailyFinance on Wed, 08 Dec 2010 22:45:00.
Filed Under: Company News, Health Care, Johnson & Johnson, Stocks in the News